Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients

Cancer Research

Volumn 58, Issue 11, 1998, Pages 2359-2365

  Hirai, Kouzo ^c   Hussey, Helen J ^a   Barber, Matthew D ^b   Price, Sarah A ^a   Tisdale, Michael J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ADENYLATE CYCLASE; ALPHA2 GLYCOPROTEIN; AMINO ACID; FATTY ACID; GLUCOSE; GLYCEROL; GUANOSINE TRIPHOSPHATE; ISOPRENALINE; LIPID; OXYGEN; PLASMA PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ZINC ALPHA2 GLYCOPROTEIN;

ADIPOCYTE; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPOLYSIS; MALE; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; URINE;

ADENYLATE CYCLASE; ADIPOCYTES; ADRENERGIC BETA-AGONISTS; ANIMALS; BODY COMPOSITION; CACHEXIA; CELLS, CULTURED; CYCLIC AMP; DIGESTIVE SYSTEM NEOPLASMS; DRINKING; EATING; FEMALE; GLYCOPROTEINS; GUANOSINE TRIPHOSPHATE; HUMANS; ISOPROTERENOL; LIPID MOBILIZATION; LIPOLYSIS; MALE; MICE; MICE, INBRED STRAINS; MICE, OBESE; OMENTUM; OVARIAN NEOPLASMS; PEPTIDES; SEMINAL PLASMA PROTEINS;

EID: 0032100584     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Heymsfield, S. B., and McManus, C. B. Tissue components of weight loss in cancer patients: a new method of study and preliminary observations. Cancer (Phila.), 55: 238-249, 1985.
2. Hussey, H. J., and Tisdale, M. J. Effect of polyunsaturated fatty acids on the growth of murine colon adenocarcinomas in vitro and in vivo. Br. J. Cancer, 70: 6-10, 1994.
3. Rose, D. P., Connolly, J. M., and Liu, X-H. Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro. Cancer Res., 54: 6557-6562, 1994.
4. Hyltander, A., Drott, C., Korner, U., Sandstrom, R., and Lundholm, K. Elevated energy expenditure in cancer patients with solid tumours. Eur. J. Cancer, 27: 9-15, 1991.
5. Tisdale, M. J., and Beck, S. A. Inhibition of tumour-induced lipolysis in vitro and cachexia and tumour growth in vivo by eicosapentaenoic acid. Biochem. Pharmacol., 41: 103-107, 1991.
6. Beck, S. A., Mulligan, H. D., and Tisdale, M. J. Lipolytic factors associated with murine and human cancer cachexia. J. Natl. Cancer Inst. (Bethesda), 82: 1922-1926, 1990.
7. Thompson, M. P., Cooper, S. T., Parry, B. R., and Tuckey, J. A. Increased expression of the mRNA for the hormone-sensitive lipase in adipose tissue of cancer patients. Biochim. Biophys. Acta, 1180: 236-241, 1993.
8. Todorov, P. T., McDevitt, T. M., Meyer, D., Ueyama, H., Ohkubo, I., and Tisdale, M. J. Purification and characterization of a tumor lipid-mobilizing factor. Cancer Res., 58: 2353-2358.
9. Wieland, O. Glycerol UV method. In: H. U. Bergmeyer (ed.), Methods of Enzymatic Analysis, pp. 1404-1409. London: Academic Press, 1974.
10. Beck, S. A., and Tisdale, M. J. Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host. Cancer Res., 47: 5919-5923, 1987.
11. Belsham, G. J., Deton, R. M., and Tanner, M. J. A. Use of a novel rapid preparation of fat-cell plasma membranes employing percoll to investigate the effects of insulin and adrenaline on membrane protein phosphorylation within intact fat cells. Biochem. J., 192: 457-467, 1980.
12. Bachman, E., Allman, D. W., and Green, D. E. The membrane systems of the mitochondria. I. The S fraction of the outer membrane of beef heart mitochondria. Arch. Biochem. Biophys. 115: 153-164, 1966.
13. Dallner, G., Siekevitz, P., and Palade, G. E. Biogenesis of endoplasmic reticulum membranes, II. Synthesis of constitutive microsomal enzymes in developing rat hepatocyte. J. Cell Biol., 30: 97-117, 1966.
14. Gutman, I., and Wahefield, A. E. L-(+)-Lactate determination with lactate dehydrogenase and NAD. In: H. U. Bergmeyer (ed.), Methods of Enzymatic Analysis, pp. 1464-1468. London: Academic Press, 1974.
15. Avruch, J., and Wallach, D. F. H. Preparation and properties of plasma membrane and endoplasmic reticulum fragments from isolated rat fat cells. Biochim. Biophys. Acta, 233: 334-347, 1971.
16. Salomon, Y., Londos, C., and Rodbell, M. A highly sensitive adenylate cyclase assay. Anal. Biochem., 58: 541-548, 1973.
17. Stralfors, P., Olsson, H., and Belfrange, P. Hormone sensitive lipase. In: P. D. Boyer and E. G. Krebs (eds.), The Enzymes, pp. 147-177. New York: Academic Press, 1987.
18. 2-glycoprotein is a novel adhesive protein. Biochem. Biophys. Res. Commun., 201: 1339-1347, 1994.
19. 2-glycoprotein and its homology to histocompatibility antigens. Proc. Natl. Acad. Sci. USA, 85: 679-683, 1988.
20. Todorov, P., Cariuk, P., McDevitt, T., Coles, B., Fearon, K., and Tisdale, M. Characterization of a cancer cachectic factor. Nature (Lond.), 379: 739-742, 1996.
21. Todorov, P. T., McDevitt, T. M., Cariuk, P., Coles, B., Deacon, M., and Tisdale, M. J. Induction of muscle protein degradation and weight loss by a tumor product. Cancer Res., 56: 1256-1261, 1996.
22. McDevitt, T. M., and Tisdale, M. J. Tumour-associated hypoglycaemia in a murine cachexia model. Br. J. Cancer, 66: 815-820, 1992.
23. 2-glycoprotein in normal human body fluids and kidney extracts. J. Lab. Clin. Med., 71: 807-811, 1968.
24. 2-glycoprotein cDNA cloning and expression analysis in benign and malignant breast tissues. FEBS Lett., 290: 247-249, 1991.
25. Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., and Collins, F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science (Washington DC), 269: 540-543, 1995.
26. Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., and Friedman, J. M. Weight reducing effects of the plasma protein encoded by the obese gene. Science (Washington DC), 269: 543-546, 1995.
27. Strassman, G., and Kambayashi, T. Inhibition of experimental cancer cachexia by anti-cytokine and anti-cytokine receptor therapy. Cytokines Mol. Ther., 1: 107-113, 1995.
28. Mahony, S. M., Beck, S. A., and Tisdale, M. J. Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour. Br. J. Cancer, 57: 385-389, 1988.
29. Grunfeld, C., and Feingold, K. R. Tumour necrosis factor, cytokines and hyperlipidemia of infection. Trends Endocrinol. Metab., 2: 213-219, 1991.
30. Gercel-Taylor, C., Doering, D. L., Kraemer, F. B., and Taylor, D. D. Aberrations in normal systemic lipid metabolism in ovarian cancer patients. Gynecol. Oncol., 60: 35-41, 1996.
31. 3-Adrenergic agonists. Drugs Future, 18: 529-549, 1993.
32. 3-adrenergic receptor gene. Mol. Pharmacol., 44: 264-270, 1993.
33. 3-adrenoceptors in human brown and white adipose tissue. Br. J. Pharmacol., 118: 929-934, 1996.